The global Gastrointestinal Drugs market size was estimated to be US$ 47 billion in 2021 and is expected grow at a CAGR of 6.1% between 2023 to 2032.Medicines for the gastrointestinal system are primarily intended to provide and treat digestive tract organs such as the liver, biliary tract, and pancreas and disorder.
/PRNewswire/ Gastrointestinal Drugs Market Research Report by Drug Category, Route of Administration, Disease Type, End User, Region - Global Forecast to.
hirenFebruary 18, 2021
The report titled “
Global Gastrointestinal Drugs Market Evolving Industry Trends and Key Insights by 2026| ZMR” and published by Zion Market Research (ZMR)is a document that aims at offering a methodical and organized explanation of the important aspects of the global Gastrointestinal Drugs Market. This will further assist the reader in better evaluation of the previous, existing, and future dynamics and situations of the global market. The report entails the market overview along with a detailed analysis of several market players competing and contributing remarkably within the market. The key players comprise:
Allergan Plc., Abbott Laboratories, Bayer AG, AstraZeneca, GlaxoSmithKline Plc., Boehringer Ingelheim GmbH., Sanofi, Janssen Biotech Inc., Valeant Pharmaceuticals Inc., and Takeda Pharmaceutical,. Further, the report encompasses a thorough assessment of the strategies such as research&development, mergers & acquisitions, new product developm